UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000023962
Receipt No. R000027510
Scientific Title Efficacy of the criterion of sarcopenia in chronic liver disease
Date of disclosure of the study information 2016/09/06
Last modified on 2021/07/20 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Efficacy of the criterion of sarcopenia in chronic liver disease
Acronym Sarcopenia in chronic liver disease
Scientific Title Efficacy of the criterion of sarcopenia in chronic liver disease
Scientific Title:Acronym Sarcopenia in chronic liver disease
Region
Japan

Condition
Condition Chronic liver disesase
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the efficacy of the criterion of the sarcopenia in chronic liver disease
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comparison of the survival span of patient with sarcopenia and non-sarcopenia
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) chronic liver disease
2) Cases obtained written informed consent
Key exclusion criteria 1) Cases regarded by doctors as inappropriate for the enrollment for some reasons
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Uojima
Middle name
Last name Haruki
Organization Kitasato University school of medicine
Division name Department of Gastroenterology
Zip code 252-0375
Address 1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0374 Japan
TEL +81-42-778-8111
Email kiruha555@yahoo.co.jp

Public contact
Name of contact person
1st name Haruki
Middle name
Last name Uojima
Organization Kitasato University School of Medicine
Division name Department of Gastroenterology
Zip code 252-0375
Address 1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0374 Japan
TEL +81-42-778-8111
Homepage URL
Email kiruha555@yahoo.co.jp

Sponsor
Institute Kitasato University School of Medicine
Institute
Department

Funding Source
Organization Kitasato University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kitasato institute hospital research ethics committee
Address 1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0374 Japan
Tel +81-42-778-8111
Email mailtorinri@med.kitasato-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 09 Month 06 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled 300
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 07 Month 01 Day
Date of IRB
2016 Year 09 Month 01 Day
Anticipated trial start date
2016 Year 09 Month 01 Day
Last follow-up date
2021 Year 04 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The new JSH criteria for sarcopenia are accurate predictors of poor prognosis in patients with liver cirrhosis.

Management information
Registered date
2016 Year 09 Month 06 Day
Last modified on
2021 Year 07 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027510